Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Linde PLC Director's Dealing 2025

Mar 4, 2025

9953_dirs_2025-03-04_66b8d505-d5c3-415b-af1f-78d0c0d9043a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LINDE PLC (LIN)
CIK: 0001707925
Period of Report: 2025-03-03

Reporting Person: Strauss David P (Executive VP, Chief HR Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-03-03 Ordinary Shares M 7545 $154 Acquired 8844.897 Direct
2025-03-03 Ordinary Shares F 5068 $469.95 Disposed 3776.897 Direct
2025-03-03 Ordinary Shares S 2477 $469.74 Disposed 1299.897 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-03-03 Stock Options (right to buy) $154 M 7545 Disposed 2028-02-27 Ordinary Shares (7545) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares 24626.2 Indirect
Ordinary Shares 1946.055 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Restricted Stock Units $ Ordinary Shares (1235) 1235 Direct
Restricted Stock Units $ Ordinary Shares (1290) 1290 Direct
Restricted Stock Units $ Ordinary Shares (1180) 1180 Direct
Stock Options (right to buy) $465.29 2034-03-07 Ordinary Shares (8010) 8010 Direct
Stock Options (right to buy) $354.14 2033-03-07 Ordinary Shares (8515) 8515 Direct
Stock Options (right to buy) $270.99 2032-03-07 Ordinary Shares (10200) 10200 Direct
Stock Options (right to buy) $253.68 2031-03-08 Ordinary Shares (15925) 15925 Direct
Stock Options (right to buy) $173.13 2030-03-09 Ordinary Shares (20870) 20870 Direct
Stock Options (right to buy) $176.63 2029-03-20 Ordinary Shares (20985) 20985 Direct
Deferred Stock Units $ Ordinary Shares (236.828) 239.778 Direct

Footnotes

F1: Ordinary shares withheld to cover exercise price and tax withholdings.

F2: The price reported is the weighted average sale price. The sale prices ranged from $469.72 to $469.95. Upon request of the SEC Staff, Linde plc or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.

F3: Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.

F4: Restricted Stock Units that will vest in full and payout on or about March 7, 2026 in Linde plc Ordinary Shares on a one-for-one basis.

F5: Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis.

F6: Restricted Stock Units that will vest in full and payout on or about March 8, 2024 in Linde plc Ordinary Shares on a one-for-one basis.

F7: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.

F8: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.

F9: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.

F10: This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.

F11: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.

F12: This option vests over three years in three consecutive equal annual installments beginning on March 20, 2020.

F13: This option vested in full three years after the grant date.

F14: Conversion to Linde plc Ordinary Shares is on a one-to-one basis.

F15: Deferred stock units acquired under the Linde Compensation Deferral Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Plan.